Neumora Therapeutics | IPO Presentation Deck | 32 slides · page 18 of 32
The slide uses a 'Signal Seeking' framework to justify clinical development decisions based on effect size.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 chart 1/1 diagram 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 6
primary bar-grouped process paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1